Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV003151529 | SCV005388325 | uncertain significance | not provided | 2024-03-27 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Missense variants in this gene are a common cause of disease and they are underrepresented in the general population; Has not been previously published as pathogenic or benign to our knowledge |
Genetic Services Laboratory, |
RCV003151529 | SCV003839554 | likely pathogenic | not provided | 2022-06-16 | no assertion criteria provided | clinical testing | DNA sequence analysis of the GCK gene demonstrated a sequence change, c.367T>C, in exon 4 that results in an amino acid change, p.Phe123Leu. The p.Phe123Leu change affects a highly conserved amino acid residue located in a domain of the GCK protein that is known to be functional. The p.Phe123Leu substitution appears to be deleterious using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). This amino acid change, p.Phe123Leu, caused by a different nucleotide change, c.369C>G, has been reported in a child with MODY (PMID: 18382660). Additionally, a different pathogenic sequence change affecting the same amino acid residue (p.Phe123Ser) has been described in an individual with MODY and their similarly affected mother (PMID: 27256595) and this amino acid change occurs in a region of the GCK gene where other missense sequence changes have been described in individuals with MODY (PMID: 31063852, 32533152). This sequence change has not been described in population databases such as ExAC and gnomAD. This sequence change is the likely cause of this individual's phenotype, however functional studies have not been performed to prove this conclusively. |